文献速递甲状腺疾病

妊娠特异性TSH和FT4参考区间:来自孕前-妊娠纵向数据的新见解

Pregnancy-specific Reference Intervals for TSH and FT4: Novel Insights From Preconception-gestation Longitudinal Data.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究基于Generation R Next前瞻性队列,比较妊娠特异性与非妊娠参考区间诊断甲状腺疾病的患病率,并评估FT3的附加价值。结果显示妊娠特异性参考区间可能过度诊断亚临床甲状腺功能减退症,而FT3在妊娠期诊断(亚)临床甲状腺疾病中价值有限。

要点

  • 妊娠特异性参考区间可能过度诊断亚临床甲状腺功能减退症。
  • 使用妊娠特异性参考区间时,妊娠期亚临床甲状腺功能亢进症患病率低于非妊娠参考区间。
  • FT3在妊娠期诊断(亚)临床甲状腺疾病中价值有限。

核心结论

  • 妊娠特异性参考区间可能过度诊断亚临床甲状腺功能减退症。
  • FT3在妊娠期诊断(亚)临床甲状腺疾病中价值有限。

研究设计与样本

  • 研究嵌入Generation R Next基于人群的前瞻性队列,从孕前至产后,在鹿特丹开展。
  • 研究人群包括孕前1058名女性和妊娠期2084名女性。

主要发现

  • 妊娠期亚临床甲状腺功能减退症患病率:使用非妊娠参考区间为1.5%,使用妊娠特异性参考区间为3.6%,孕前为2.2%。
  • 妊娠期亚临床甲状腺功能亢进症患病率:使用非妊娠参考区间为11.1%,使用妊娠特异性参考区间为1.5%,孕前为2.0%。
  • 额外FT3测量在孕前将5.6%的亚临床甲状腺功能亢进症病例重新分类为甲状腺功能亢进症,妊娠期为14.3%。

临床怎么用

  • 临床诊断妊娠期甲状腺疾病时,需注意妊娠特异性参考区间可能过度诊断亚临床甲状腺功能减退症。
  • FT3在妊娠期诊断(亚)临床甲状腺疾病中价值有限,不应常规依赖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pregnancy-specific changes in thyroid physiology have prompted the use of pregnancy-specific reference intervals to diagnose thyroid disease. However, such reference intervals are not widely available, and there is no evidence of their superiority over nonpregnancy reference intervals. Preconception data are understudied benchmarks to compare pregnancy-specific and nonpregnancy reference intervals. Moreover, the added value of free T3 (FT3) measurements, for example in cases of (subclinical) hyperthyroidism, remains to be quantified. METHODS: This study was embedded within Generation R Next, a population-based prospective cohort from preconception through postpartum in Rotterdam. Prevalence of thyroid disease entities was assessed using both pregnancy-specific and nonpregnancy reference intervals during pregnancy and using nonpregnancy reference intervals in the preconception period. FT3 concentrations of both euthyroid participants and those with thyroid disease entities were compared in the preconception period and during pregnancy. RESULTS: The study population included 1058 women during preconception and 2084 women during pregnancy. The prevalence of subclinical hypothyroidism during pregnancy was 1.5% with the use of nonpregnancy reference intervals and 3.6% with pregnancy-specific reference intervals vs 2.2% during preconception. The prevalence of subclinical hyperthyroidism during pregnancy was 11.1% with the use of nonpregnancy reference intervals and 1.5% with pregnancy-specific reference intervals vs 2.0% during preconception. Additional FT3 measurements reclassified 5.6% of subclinical hyperthyroidism cases to hyperthyroidism during preconception and 14.3% during pregnancy. CONCLUSION: This is the first study to assess the prevalence of (sub)clinical thyroid disease during pregnancy comparing nonpregnancy and pregnancy-specific reference intervals, while also comparing these prevalences to preconception data from the same source population. We show that pregnancy-specific reference intervals likely result in overdiagnosis of subclinical hypothyroidism and that FT3 has limited value in diagnosing (sub)clinical thyroid disease during pregnancy.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Warringa LTL, Osinga JAJ, Derakhshan A, et al. Pregnancy-specific Reference Intervals for TSH and FT4: Novel Insights From Preconception-gestation Longitudinal Data. J Clin Endocrinol Metab. 2026. PMID: 41762673. doi:10.1210/clinem/dgag082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。